Evidence map›Paper›PMID 34567553›Full record

ArticleClinical case reports2021

A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.

Takaya Takeuchi, Yunosuke Matsuura, Yoshimasa Yamamura, Momoko Ohkusu, Shohei Koyama, Takeshi Kawaguchi, Mayumi Akaki Nagayasu, Hiroyuki Komatsu, Akihiko Okayama, Tetsunori Ishikawa and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Takaya TakeuchiDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.
Yunosuke MatsuuraDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.ORCID 0000-0003-2927-7284
Yoshimasa YamamuraDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.
Momoko OhkusuCenter for Post-Graduation Clinical Training Faculty of Medicine University of Miyazaki Miyazaki Japan.
Shohei KoyamaDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.
Takeshi KawaguchiDepartment of Rheumatology Infectious Diseases and Laboratory Medicine University of Miyazaki Miyazaki Japan.
Mayumi Akaki NagayasuClinical Laboratory University of Miyazaki Hospital Miyazaki Japan.
Hiroyuki KomatsuCenter for Post-Graduation Clinical Training Faculty of Medicine University of Miyazaki Miyazaki Japan.
Akihiko OkayamaDepartment of Rheumatology Infectious Diseases and Laboratory Medicine University of Miyazaki Miyazaki Japan.
Tetsunori IshikawaDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.
Tatsuya AtsumiDepartment of Rheumatology, Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan.
Kazuo KitamuraDepartment of Internal Medicine, Circulatory and Body Fluid Regulation University of Miyazaki Miyazaki Japan.
University of Miyazaki · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a "platelet dilemma" in therapeutic decision-making.

Indexed as

anti‐thrombotic therapyimmune thrombocytopeniavenous thromboembolism

Identifiers

PMID34567553
PMCPMC8449094
OpenAlexW3200456650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.